Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an
 occupational therapist-delivered primary care intervention for aging and chronic disease
 management.
The IPROACTIF intervention is based on the premise of preventing the physical and cognitive
 decline that is associated with aging and chronic disease. The 12-week intervention includes
 a comprehensive assessment of ADL functioning and ten intervention sessions addressing
 disease management, physical activity and executive functioning. This pilot randomized
 control trial will compare whether patients who receive IPROACTIF perform better than usual
 care patients on physical functioning, self-efficacy for chronic disease management, physical
 activity levels, executive functioning, health-related quality of life, and participation in
 life roles and activities.
Inclusion Criteria:

 -  English speaking

 -  Community-dwelling

 -  55 years of age

 -  Primary diagnosis of heart disease (coronary artery disease, ischemic heart disease,
 hypertensive heart disease), or uncontrolled diabetes (HBA1c greater than/equal to 10)

 -  Self-reported risk of functional decline (score of 3 or higher) on the 11-item Brief
 Risk Identification of Geriatric Health Tool or self-reported need for assistance with
 disease management

 Exclusion Criteria

 -  Current/past diagnosis of stroke or other neurological disorders

 -  Receiving pharmacological treatment for cognition

 -  Receiving outpatient rehabilitation services

 -  Participating in other exercise or ADL-focused intervention studies

 -  Non-English speaking

 -  Residing in a long-term care institution

 -  Compromised decision-making capacity (score >8 on SOMCT)